BIOMAT Database Logo BIOMAT Database Logo

Synthesis and antiviral evaluation of base-modified deoxythreosyl nucleoside phosphonates. 2017

Chao Liu, and Shrinivas G Dumbre, and Christophe Pannecouque, and Brent Korba, and Steven De Jonghe, and Piet Herdewijn
KU Leuven, Rega Institute for Medical Research, Medicinal Chemistry, Herestraat 49, 3000 Leuven, Belgium. Piet.Herdewijn@kuleuven.be.

l-α-2'-Deoxythreosyl nucleoside phosphonates and their phosphonodiamidate prodrugs with a hypoxanthine, 2,6-diaminopurine, 2-amino-6-cyclopropylaminopurine, 7-deazaadenine, 5-fluorouracil and 5-methylcytosine heterocycle as a nucleobase were synthesized and evaluated for their inhibitory activity against HIV and HBV. The 2,6-diaminopurine modified analogue 23a displayed the most potent activity against HIV, with an EC50 value of 11.17 μM against HIV-1 (IIIB) and an EC50 value of 8.15 μM against HIV-2 (ROD). The application of the prodrug strategy on nucleoside phosphonate 23a led to a 200-fold boost in anti-HIV potency. None of the compounds showed any activity against HBV at the highest concentration tested.

UI MeSH Term Description Entries
D008826 Microbial Sensitivity Tests Any tests that demonstrate the relative efficacy of different chemotherapeutic agents against specific microorganisms (i.e., bacteria, fungi, viruses). Bacterial Sensitivity Tests,Drug Sensitivity Assay, Microbial,Minimum Inhibitory Concentration,Antibacterial Susceptibility Breakpoint Determination,Antibiogram,Antimicrobial Susceptibility Breakpoint Determination,Bacterial Sensitivity Test,Breakpoint Determination, Antibacterial Susceptibility,Breakpoint Determination, Antimicrobial Susceptibility,Fungal Drug Sensitivity Tests,Fungus Drug Sensitivity Tests,Sensitivity Test, Bacterial,Sensitivity Tests, Bacterial,Test, Bacterial Sensitivity,Tests, Bacterial Sensitivity,Viral Drug Sensitivity Tests,Virus Drug Sensitivity Tests,Antibiograms,Concentration, Minimum Inhibitory,Concentrations, Minimum Inhibitory,Inhibitory Concentration, Minimum,Inhibitory Concentrations, Minimum,Microbial Sensitivity Test,Minimum Inhibitory Concentrations,Sensitivity Test, Microbial,Sensitivity Tests, Microbial,Test, Microbial Sensitivity,Tests, Microbial Sensitivity
D004305 Dose-Response Relationship, Drug The relationship between the dose of an administered drug and the response of the organism to the drug. Dose Response Relationship, Drug,Dose-Response Relationships, Drug,Drug Dose-Response Relationship,Drug Dose-Response Relationships,Relationship, Drug Dose-Response,Relationships, Drug Dose-Response
D006515 Hepatitis B virus The type species of the genus ORTHOHEPADNAVIRUS which causes human HEPATITIS B and is also apparently a causal agent in human HEPATOCELLULAR CARCINOMA. The Dane particle is an intact hepatitis virion, named after its discoverer. Non-infectious spherical and tubular particles are also seen in the serum. Dane Particle,Hepatitis Virus, Homologous Serum,B virus, Hepatitis,Hepatitis B viruses,Particle, Dane,viruses, Hepatitis B
D000998 Antiviral Agents Agents used in the prophylaxis or therapy of VIRUS DISEASES. Some of the ways they may act include preventing viral replication by inhibiting viral DNA polymerase; binding to specific cell-surface receptors and inhibiting viral penetration or uncoating; inhibiting viral protein synthesis; or blocking late stages of virus assembly. Antiviral,Antiviral Agent,Antiviral Drug,Antivirals,Antiviral Drugs,Agent, Antiviral,Agents, Antiviral,Drug, Antiviral,Drugs, Antiviral
D013329 Structure-Activity Relationship The relationship between the chemical structure of a compound and its biological or pharmacological activity. Compounds are often classed together because they have structural characteristics in common including shape, size, stereochemical arrangement, and distribution of functional groups. Relationship, Structure-Activity,Relationships, Structure-Activity,Structure Activity Relationship,Structure-Activity Relationships
D015394 Molecular Structure The location of the atoms, groups or ions relative to one another in a molecule, as well as the number, type and location of covalent bonds. Structure, Molecular,Molecular Structures,Structures, Molecular
D015497 HIV-1 The type species of LENTIVIRUS and the etiologic agent of AIDS. It is characterized by its cytopathic effect and affinity for the T4-lymphocyte. Human immunodeficiency virus 1,HIV-I,Human Immunodeficiency Virus Type 1,Immunodeficiency Virus Type 1, Human
D015498 HIV-2 An HIV species related to HIV-1 but carrying different antigenic components and with differing nucleic acid composition. It shares serologic reactivity and sequence homology with the simian Lentivirus SIMIAN IMMUNODEFICIENCY VIRUS and infects only T4-lymphocytes expressing the CD4 phenotypic marker. HTLV-IV,Human T-Lymphotropic Virus Type IV,Human immunodeficiency virus 2,LAV-2,HIV-II,Human Immunodeficiency Virus Type 2,Human T Lymphotropic Virus Type IV,Immunodeficiency Virus Type 2, Human,SBL-6669
D063065 Organophosphonates Carbon-containing phosphonic acid compounds. Included under this heading are compounds that have carbon bound to either OXYGEN atom or the PHOSPHOROUS atom of the (P Phosphonate,Phosphonates,Phosphonic Acid Esters,Acid Esters, Phosphonic,Esters, Phosphonic Acid

Related Publications

Chao Liu, and Shrinivas G Dumbre, and Christophe Pannecouque, and Brent Korba, and Steven De Jonghe, and Piet Herdewijn
Synthesis and antiviral evaluation of cyclopentyl nucleoside phosphonates.
April 2018, European journal of medicinal chemistry,
Chao Liu, and Shrinivas G Dumbre, and Christophe Pannecouque, and Brent Korba, and Steven De Jonghe, and Piet Herdewijn
Synthesis and Antiviral Evaluation of 3'-Fluoro-4'-modified-5'-norcarbocyclic Nucleoside Phosphonates.
March 2019, ChemMedChem,
Chao Liu, and Shrinivas G Dumbre, and Christophe Pannecouque, and Brent Korba, and Steven De Jonghe, and Piet Herdewijn
Synthesis of Methylenecyclopropane Analogues of Antiviral Nucleoside Phosphonates.
March 2006, Tetrahedron,
Chao Liu, and Shrinivas G Dumbre, and Christophe Pannecouque, and Brent Korba, and Steven De Jonghe, and Piet Herdewijn
Synthesis and application of novel nucleoside phosphonates and phosphoramidites modified at the base moiety.
January 1996, Acta biochimica Polonica,
Chao Liu, and Shrinivas G Dumbre, and Christophe Pannecouque, and Brent Korba, and Steven De Jonghe, and Piet Herdewijn
Synthesis of novel 3'-hydroxymethyl 5'-deoxythreosyl phosphonic acid nucleoside analogues as potent antiviral agents.
January 2012, Nucleosides, nucleotides & nucleic acids,
Chao Liu, and Shrinivas G Dumbre, and Christophe Pannecouque, and Brent Korba, and Steven De Jonghe, and Piet Herdewijn
Synthesis and Antiviral Evaluation of 3'-Fluoro-5'-norcarbocyclic Nucleoside Phosphonates Bearing Uracil and Cytosine as Potential Antiviral Agents.
August 2020, Molecules (Basel, Switzerland),
Chao Liu, and Shrinivas G Dumbre, and Christophe Pannecouque, and Brent Korba, and Steven De Jonghe, and Piet Herdewijn
New prodrugs of two pyrimidine acyclic nucleoside phosphonates: Synthesis and antiviral activity.
September 2017, Bioorganic & medicinal chemistry,
Chao Liu, and Shrinivas G Dumbre, and Christophe Pannecouque, and Brent Korba, and Steven De Jonghe, and Piet Herdewijn
Synthesis, antiviral activity, and computational study of β-d-xylofuranosyl nucleoside phosphonates.
July 2023, European journal of medicinal chemistry,
Chao Liu, and Shrinivas G Dumbre, and Christophe Pannecouque, and Brent Korba, and Steven De Jonghe, and Piet Herdewijn
Synthesis of novel 2'-fluoro-3'-hydroxymethyl-5'-deoxythreosyl phosphonic acid nucleoside analogues as antiviral agents.
January 2014, Nucleosides, nucleotides & nucleic acids,
Chao Liu, and Shrinivas G Dumbre, and Christophe Pannecouque, and Brent Korba, and Steven De Jonghe, and Piet Herdewijn
Synthesis of fluorinated acyclic nucleoside phosphonates with 5-azacytosine base moiety.
September 2019, Tetrahedron,
Copied contents to your clipboard!